Literature DB >> 26322924

Modeling the Health Effects of Expanding e-Cigarette Sales in the United States and United Kingdom: A Monte Carlo Analysis.

Sara Kalkhoran1, Stanton A Glantz2.   

Abstract

IMPORTANCE: The prevalence of electronic cigarette (e-cigarette) use is increasing. Population health effects will depend on cigarette smoking behaviors, levels of dual use with conventional cigarettes, and e-cigarette toxicity.
OBJECTIVE: To evaluate potential health effects of various scenarios of increasing promotion and use of e-cigarettes. DESIGN, SETTING, AND PARTICIPANTS: A base case model was developed using data on actual cigarette and e-cigarette use patterns that quantifies transitions from an initial state of no cigarette or e-cigarette use to 1 of 5 final states: never use of cigarettes or e-cigarettes, cigarette use, e-cigarette use, dual use of cigarettes and e-cigarettes, or quit. Seven scenarios were created that cover a range of use patterns, depending on how the e-cigarette market might develop, as well as a range of possible long-term health effects of e-cigarette use. Scenarios for changes from the base case were evaluated using Monte Carlo simulations. Separate sets of base case model parameters were evaluated for the US and UK populations. MAIN OUTCOMES AND MEASURES: We assigned unitless health "costs" for each final state on a scale of 0 to 100. Population health "costs" were compared with the base case (status quo) assuming e-cigarette use health "costs" from 1% to 50% as dangerous as conventional cigarette use health costs.
RESULTS: Compared with the base case, a harm reduction scenario in which e-cigarette use increases only among smokers who are interested in quitting with more quit attempts and no increased initiation of e-cigarette use among nonsmokers, and another scenario in which e-cigarettes are taken up only by youth who would have smoked conventional cigarettes, had population-level health benefits regardless of e-cigarette health costs in both the United States and United Kingdom. Conversely, scenarios in which e-cigarette promotion leads to renormalization of cigarette smoking or e-cigarettes are used primarily by youth who never would have smoked showed net health harms across all e-cigarette health costs. In other scenarios, the net health effect varied on the basis of the health cost of e-cigarettes. CONCLUSIONS AND RELEVANCE: According to this analysis, widespread promotion of e-cigarettes may have a wide range of population-level health effects, depending on both e-cigarette health risks and patterns of use. Absent the primary effect of e-cigarette promotion being only to divert current or future conventional cigarette smokers to e-cigarette use, the current uncertainty about the health risks of e-cigarettes, increasing e-cigarette use among youth, and the varying health effects at different e-cigarette health costs suggest a potential for harm.

Entities:  

Mesh:

Year:  2015        PMID: 26322924      PMCID: PMC4594196          DOI: 10.1001/jamainternmed.2015.4209

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


  50 in total

1.  Quitting smoking among adults--United States, 2001-2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-11-11       Impact factor: 17.586

2.  Electronic cigarettes: a policy statement from the American Heart Association.

Authors:  Aruni Bhatnagar; Laurie P Whitsel; Kurt M Ribisl; Chris Bullen; Frank Chaloupka; Mariann R Piano; Rose Marie Robertson; Timothy McAuley; David Goff; Neal Benowitz
Journal:  Circulation       Date:  2014-08-24       Impact factor: 29.690

3.  Reversal of risk upon quitting smoking.

Authors:  Carolyn M Dresler; Maria E León; Kurt Straif; Robert Baan; Béatrice Secretan
Journal:  Lancet       Date:  2006-07-29       Impact factor: 79.321

4.  The renormalization of smoking? E-cigarettes and the tobacco "endgame".

Authors:  Amy L Fairchild; Ronald Bayer; James Colgrove
Journal:  N Engl J Med       Date:  2013-12-18       Impact factor: 91.245

5.  Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.

Authors:  Edward J Mills; Kristian Thorlund; Shawn Eapen; Ping Wu; Judith J Prochaska
Journal:  Circulation       Date:  2013-12-09       Impact factor: 29.690

6.  Levels of selected carcinogens and toxicants in vapour from electronic cigarettes.

Authors:  Maciej Lukasz Goniewicz; Jakub Knysak; Michal Gawron; Leon Kosmider; Andrzej Sobczak; Jolanta Kurek; Adam Prokopowicz; Magdalena Jablonska-Czapla; Czeslawa Rosik-Dulewska; Christopher Havel; Peyton Jacob; Neal Benowitz
Journal:  Tob Control       Date:  2013-03-06       Impact factor: 7.552

7.  Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study.

Authors:  Jamie Brown; Emma Beard; Daniel Kotz; Susan Michie; Robert West
Journal:  Addiction       Date:  2014-09       Impact factor: 6.526

8.  Current cigarette smoking among adults - United States, 2005-2012.

Authors:  Israel T Agaku; Brian A King; Shanta R Dube
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-01-17       Impact factor: 17.586

9.  Tobacco product use among adults--United States, 2012-2013.

Authors:  Israel T Agaku; Brian A King; Corinne G Husten; Rebecca Bunnell; Bridget K Ambrose; S Sean Hu; Enver Holder-Hayes; Hannah R Day
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-06-27       Impact factor: 17.586

10.  Tobacco use among middle and high school students--United States, 2013.

Authors:  René A Arrazola; Linda J Neff; Sara M Kennedy; Enver Holder-Hayes; Christopher D Jones
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-11-14       Impact factor: 17.586

View more
  40 in total

1.  E-Cigarette Use and Future Cigarette Initiation Among Never Smokers and Relapse Among Former Smokers in the PATH Study.

Authors:  Robert McMillen; Jonathan D Klein; Karen Wilson; Jonathan P Winickoff; Susanne Tanski
Journal:  Public Health Rep       Date:  2019-08-16       Impact factor: 2.792

2.  Developing Consistent and Transparent Models of E-cigarette Use: Reply to Glantz and Soneji et al.

Authors:  David T Levy; Ron Borland; Geoffrey T Fong; Andrea C Villanti; Raymond Niaura; Rafael Meza; Theodore R Holford; K Michael Cummings; David B Abrams
Journal:  Nicotine Tob Res       Date:  2016-10-06       Impact factor: 4.244

3.  Need for Examination of Broader Range of Risks When Predicting the Effects of New Tobacco Products.

Authors:  Stanton A Glantz
Journal:  Nicotine Tob Res       Date:  2016-10-06       Impact factor: 4.244

4.  Managing nicotine without smoke to save lives now: Evidence for harm minimization.

Authors:  David B Abrams; Allison M Glasser; Andrea C Villanti; Jennifer L Pearson; Shyanika Rose; Raymond S Niaura
Journal:  Prev Med       Date:  2018-06-23       Impact factor: 4.018

5.  Documentation of e-cigarette use and associations with smoking from 2012 to 2015 in an integrated healthcare delivery system.

Authors:  Kelly C Young-Wolff; Daniella Klebaner; Bruce Folck; Andy S L Tan; Renee Fogelberg; Varada Sarovar; Judith J Prochaska
Journal:  Prev Med       Date:  2018-01-31       Impact factor: 4.018

6.  Reply to "Letter to the Editor: Pulmonary toxicity of electronic cigarettes: more doubts than certainties".

Authors:  Lauren F Chun; Farzad Moazed; Carolyn S Calfee; Michael A Matthay; Jeffrey E Gotts
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-11-01       Impact factor: 5.464

7.  Association of Noncigarette Tobacco Product Use With Future Cigarette Smoking Among Youth in the Population Assessment of Tobacco and Health (PATH) Study, 2013-2015.

Authors:  Shannon Lea Watkins; Stanton A Glantz; Benjamin W Chaffee
Journal:  JAMA Pediatr       Date:  2018-02-01       Impact factor: 16.193

8.  Integrating Social Dynamics Into Modeling Cigarette and E-Cigarette Use.

Authors:  Kar-Hai Chu; Ariel Shensa; Jason B Colditz; Jaime E Sidani; Beth L Hoffman; David Sinclair; Mary G Krauland; Brian A Primack
Journal:  Health Educ Behav       Date:  2020-02-24

Review 9.  E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis.

Authors:  Sara Kalkhoran; Stanton A Glantz
Journal:  Lancet Respir Med       Date:  2016-01-14       Impact factor: 30.700

10.  The Application of a Decision-Theoretic Model to Estimate the Public Health Impact of Vaporized Nicotine Product Initiation in the United States.

Authors:  David T Levy; Ron Borland; Andrea C Villanti; Raymond Niaura; Zhe Yuan; Yian Zhang; Rafael Meza; Theodore R Holford; Geoffrey T Fong; K Michael Cummings; David B Abrams
Journal:  Nicotine Tob Res       Date:  2016-07-14       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.